Transport Protein Study May Lead to New Therapies for Psychiatric Disorders

Scientists at the Columbia University Irving Medical Center (CUIMC) report that they have found new evidence of how certain transport proteins are working at the molecular level, paving the way for new, improved drugs to treat psychiatric disorders. Their study (“ The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites ”) is published in PNAS .“ Crystal structures of the neurotransmitter:sodium symporter MhsT revealed occluded inward-facing states with one